gms | German Medical Science

28th Annual Meeting of the German Drug Utilisation Research Group (GAA)

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie

11.11. - 12.11.2021, digital


Meeting Abstract (21gaa01)

Reduction of medicines by GPs in frail elderly patients using a standardised deprescribing manual during family conferences – the COFRAIL study

Bencheva V, Gogolin M, Mann NK, Schmiedl S, Abraham J, Drewelow E, Ritzke M, Icks A, Mortsiefer A, Wiese B, Wilm S, Thürmann PA
[Full Text]
Meeting Abstract (21gaa02)

Prioritisation of adverse drug events leading to hospital admission and occurring during hospitalisation: A RAND survey

Böhmer A, Härdtlein A, Rottenkolber M, Pudritz YM, Dreischulte T, Jaehde U
[Full Text]
Meeting Abstract (21gaa03)

A prospective study on the tolerability of vaccines against SARS-CoV-2 in hospital staff

Dedroogh S, Graf K, Schmiedl S, Thürmann PA, Koß R, Theis C, Tebbenjohanns J, Thal S, Dedroogh M
[Full Text]
Meeting Abstract (21gaa04)

Guidelines for drug therapy after osteoporosis-associated bone fractures: to what extent are they followed in everyday practice?

Eichler U, Langner I, Schüssel K, Selke GW
[Full Text]
Meeting Abstract (21gaa05)

Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave

Enners S, Gradl G, Kieble M, Böhm M, Laufs U, Schulz M
[Full Text]
Meeting Abstract (21gaa06)

Cannabis-Report 2020 – An analysis of prescriptions of cannabinoid-based medicinal products based on data of the Mobil health insurance from 2017 until October 2019

Glaeske G, Muth L
[Full Text]
Meeting Abstract (21gaa07)

Prescription of potentially teratogenic drugs in women of childbearing age and during first trimester of pregnancy in a large cohort of statutory health insured women

Lappe V, Schubert I, Grandt D
[Full Text]
Meeting Abstract (21gaa08)

Updating and expanding the PRISCUS list – Results from the Delphi survey

Mann NK, Mathes T, Sönnichsen A, Pieper D, Moussa M, Thürmann PA
[Full Text]
Meeting Abstract (21gaa09)

Differential effects of beta-blocker exposures in predicting specific readmissions for heart failure and myocardial infarction

Meid A, Wirbka L, Ruff C, Haefeli W
[Full Text]
Meeting Abstract (21gaa10)

Bewertungskriterien für Gesundheitsapps zur Unterstützung der Medikamenteneinnahme in frühen Entwicklungsphasen der Technologie – ein Scoping Review

Niemann A, Hüer T, Neumann A, Wasem J, Neusser S
[Full Text]
Meeting Abstract (21gaa11)

Risk of fall injuries while taking hypnotics, antidepressants, and analgesics

Oehler P, Rottenkolber M, Drey M, Gensichen J, Dreischulte T
[Full Text]
Meeting Abstract (21gaa12)

From vaccine approval to reimbursement: an analysis of discrepancies between label according to marketing authorization and indication for reimbursement listed in the Vaccination Policy (SI-RL) in Germany

Prünte L, Barth M, Urban J
[Full Text]
Meeting Abstract (21gaa13)

Melanoma reported as an adverse drug reaction

Sachs B, Dubrall D, Kraywinkel K, Schulz M, Schmid M, Bäte J, Fischer-Barth W
[Full Text]
Meeting Abstract (21gaa14)

Changes in drug prescriptions during the SARS-CoV-2 pandemic

Schüssel K, Selke GW
[Full Text]
Meeting Abstract (21gaa15)

Corona pandemic-related differences in drug prescriptions within the outpatient treatment of the Statutory Health Insurance in Schleswig-Holstein from 2019 until 2020

Schuster R, Emcke T
[Full Text]
Meeting Abstract (21gaa16)

Serious Adverse Drug Reactions of Fluoroquinolones: a Pharmacoepidemiological Real World Data Analysis – Study Protocol

Wicherski J, Heß S, Röthlein C, Schüssel K, Brückner G, Schlotmann A, Schröder H, Kern W, Weltermann B, Haenisch B
[Full Text]
Meeting Abstract (21gaa17)

The Role of adherence to multiple guideline medications in predicting specific readmissions for heart failure and myocardial infarction

Wirbka L, Ruff C, Haefeli W, Meid A
[Full Text]